PNOC025: A PHASE 1 STUDY ASSESSING THE SAFETY AND TOLERABILITY OF MAGROLIMAB IN CHILDREN AND ADULTS WITH RECURRENT OR PROGRESSIVE MALIGNANT BRAIN TUMORS

Authors
Category Primary study
Conference7th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies, WFNOS and 30th Society for Neuro-Oncology Annual Meeting, SNO
Year 2025
This article has no abstract
Epistemonikos ID: cff8f14ad4dc51f329cffa646799612d7f877e79
First added on: Dec 12, 2025